CA
VXRT

Centerpoint Advisors’s Vaxart VXRT Stock Holding History

Centerpoint Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed – – 469
2021
Q3 		$0 Hold
50
– – ﹤0.01% 318
2021
Q2 		$0 Sell
50
-100
-67% -$698 ﹤0.01% 310
2021
Q1 		$1K Buy
150
+50
+50% +$385 ﹤0.01% 261
2020
Q4 		$1K Buy
+100
New +$636 ﹤0.01% 240
2020
Q3 		– Sell
-200
Closed -$2K – 283
2020
Q2 		$2K Buy
+200
New +$575 ﹤0.01% 249

Other funds holding VXRT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Centerpoint Advisors's VXRT Position: Q4 2021 in Review

Centerpoint Advisors sold out of Vaxart (VXRT) in Q4 2021, closing a stake of 50 shares.

Centerpoint Advisors first reported a position in VXRT in Q2 2020 and held it in 5 quarters. The position peaked at $2K in Q2 2020. 147 funds tracked by Wall St. Rank hold VXRT as of Q4 2021.

  • Centerpoint Advisors reported no remaining Vaxart position as of Q4 2021 after selling out during the quarter.
  • Centerpoint Advisors sold 50 Vaxart shares in Q4 2021.
  • Centerpoint Advisors first reported a position in Vaxart in Q2 2020 and held it in 5 quarters.
  • Centerpoint Advisors's Vaxart position peaked at $2K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held Vaxart as of Q4 2021.

Based on Centerpoint Advisors's 13F filing for Q4 2021, filed 14 Jan 2022.